Invesco Pharmaceuticals State Street ETFs: Which Is Better?
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Index funds and ETFs each have roles; this note explains when index funds offer a simpler, cost-effective path for many investors.
26,693 articlesTwo popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Rising yields and a search for global income are pushing retirees to shift away from SCHD toward two international di...
As inflation cools and markets wobble, a quartet of monthly-pay ETFs now offers 6% to 9% yields. This article explain...
Three dividend ETFs stand out as 2026 nears: SCHD for cost and broad exposure, HDV for quality screening, and DGRO fo...
The 2-year Treasury yield has topped 4%, drawing retirees into short-duration income funds. Two ETFs lead the pack, o...
Volatility persists into March 2026, prompting a new, diversified approach to cash flow. A four-ETF plan could target...
Institutional investors are pouring money back into XRP ETFs, driving inflows to a five-month high. Analysts say this...
Investors can gain exposure to Bill Ackman’s top stocks without buying Pershing Square. A trio of ETFs offers a cost-...
Parag Agrawal’s startup is launching Index to quantify how AI agents use publisher content and to compensate creators...
February can feel like a shifting tide for the S&P 500. This guide shares how to invest smartly this month with a cle...
As 2026 unfolds, investors eye three key covered call ETFs for steady monthly income. This analysis compares ISPY, JE...
With savings yields retreating as the Fed eases policy, two utility ETFs offer a compelling mix of income and upside....